Cargando…
Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic
OBJECTIVES: Epithelial ovarian cancer (EOC) is an aggressive disease in which first line therapy consists of a surgical staging/debulking procedure and platinum based chemotherapy. There is significant interest in clinically applicable, easy to use prognostic tools to estimate risk of recurrence and...
Autores principales: | Hendrickson, Andrea Wahner, Hawthorne, Kieran M., Goode, Ellen L., Kalli, Kimberly R., Goergen, Krista M., Bakkum-Gamez, Jamie N., Cliby, William A., Keeney, Gary L., Visscher, Dan W., Tarabishy, Yaman, Oberg, Ann L., Hartmann, Lynn C., Maurer, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380608/ https://www.ncbi.nlm.nih.gov/pubmed/25620544 http://dx.doi.org/10.1016/j.ygyno.2015.01.539 |
Ejemplares similares
-
EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
por: Mehner, Christine, et al.
Publicado: (2017) -
The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
por: Preston, Claudia C., et al.
Publicado: (2013) -
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015) -
CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021) -
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
por: Ray, Upasana, et al.
Publicado: (2021)